Axcelis Technologies Inc
ACLS Nasdaq Special Industry Machinery, Nec Financials FY2016βFY2025
What Axcelis Technologies Inc does
No business description yet.
- Legal name
- AXCELIS TECHNOLOGIES INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001104659-26-020461
0001113232
Revenue and margins
Axcelis Technologies Inc had $839M of revenue in fiscal 2025, down 17.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 29.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $107M in fiscal 2025, 12.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Axcelis Technologies Inc returned $121M to shareholders in fiscal 2025, 113% of free cash flow. The diluted share count fell 3.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Axcelis Technologies Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $295M | $432M | $506M | $571M | $374M |
| Interest coverage | 26.3x | 38.1x | 49.7x | 38.6x | 22.2x |
| Current ratio | 4.1x | 3.5x | 3.8x | 5.4x | 4.8x |
| Quick ratio | 2.8x | 2.6x | 2.7x | 4.1x | 3.1x |
| Total assets | $753M | $1.0B | $1.3B | $1.3B | $1.4B |
| Total liabilities | $214M | $346M | $417M | $336M | $327M |
| Shareholders' equity | $539M | $667M | $865M | $1.0B | $1.0B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 5 / 8 | 4 / 8 | 6 / 8 | 6 / 8 | 7 / 8 | 5 / 8 | 5 / 8 | 4 / 8 |
| Accruals ratio | 6.5% | 17.9% | β0.2% | 5.6% | β3.4% | β7.5% | β3.7% | 7.8% | 4.6% | 0.1% |
| Altman Z'' | 3.08 | 5.55 | 6.59 | 6.56 | 7.74 | 7.76 | 7.89 | 8.45 | 9.81 | 8.71 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $267M | $411M | $443M | $343M | $475M | $662M | $920M | $1.1B | $1.0B | $839M |
| Provision for credit losses | β | β | β | $0.8M | β | β | β | $1.1M | $3.4M | β |
| Gross profit | $99.6M | $150M | $180M | $144M | $199M | $286M | $402M | $491M | $455M | $377M |
| Research and development | $34.4M | $43.1M | $51.9M | $53.9M | $61.8M | $65.4M | $78.4M | $96.9M | $105M | $109M |
| Operating income | $16.6M | $47.8M | $60.0M | $24.2M | $58.0M | $127M | $212M | $266M | $211M | $119M |
| Interest expense | $5.1M | $5.1M | $5.1M | $5.2M | $5.2M | $4.8M | $5.6M | $5.3M | $5.5M | $5.4M |
| Pretax income | $11.0M | $43.8M | $54.7M | $20.9M | $55.9M | $120M | $205M | $279M | $230M | $138M |
| Income tax | $0.0M | β$83.1M | $8.8M | $3.9M | $5.9M | $21.8M | $21.8M | $32.3M | $29.3M | $18.0M |
| Net income | $11.0M | $127M | $45.9M | $17.0M | $50.0M | $98.7M | $183M | $246M | $201M | $120M |
| Net income to common | $11.0M | $127M | $45.9M | $17.0M | $50.0M | $98.7M | $183M | $246M | $201M | β |
| Diluted EPS | $0.36 | $3.80 | $1.35 | $0.50 | $1.46 | $2.88 | $5.46 | $7.43 | $6.15 | $3.80 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β$8.8M | $56.3M | $47.0M | β$13.6M | $69.7M | $150M | $216M | $157M | $141M | $118M |
| Capital expenditure | $2.5M | $7.3M | $4.7M | $12.0M | $7.4M | $8.7M | $10.7M | $20.7M | $12.2M | $11.3M |
| Free cash flow | β$11.3M | $49.0M | $42.3M | β$25.6M | $62.3M | $141M | $205M | $136M | $129M | $107M |
| Depreciation and amortization | $4.3M | $5.0M | $5.8M | $7.9M | $9.9M | $10.8M | $11.6M | $13.1M | $15.8M | $17.6M |
| Stock-based compensation | $5.2M | $5.7M | $7.8M | $8.2M | $10.5M | $12.1M | $13.4M | $18.3M | $21.0M | $20.8M |
| Share buybacks | β | β | β | $17.7M | $7.5M | $50.0M | $57.5M | $52.5M | $60.5M | $121M |
| Dividends and buybacks | β | β | β | $17.7M | $7.5M | $50.0M | $57.5M | $52.5M | $60.5M | $121M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $70.8M | $133M | $178M | $140M | $203M | $295M | $432M | $506M | $571M | $374M |
| Finance lease liabilities | β | β | β | $48.5M | $48.1M | $47.4M | $46.4M | $45.2M | $43.7M | $42.3M |
| Current assets | $241M | $340M | $397M | $376M | $471M | $619M | $878M | $1.1B | $1.1B | $943M |
| Current liabilities | $47.7M | $79.3M | $85.0M | $68.7M | $84.4M | $150M | $248M | $285M | $208M | $198M |
| Inventory | $114M | $121M | $129M | $140M | $161M | $195M | $242M | $306M | $282M | $329M |
| Property and equipment, net | $30.8M | $36.2M | $41.1M | $25.3M | $29.8M | $35.0M | $39.7M | $54.0M | $53.8M | $56.1M |
| Total assets | $302M | $488M | $548M | $548M | $625M | $753M | $1.0B | $1.3B | $1.3B | $1.4B |
| Total liabilities | $101M | $135M | $140M | $129M | $143M | $214M | $346M | $417M | $336M | $327M |
| Shareholders' equity | $201M | $354M | $408M | $419M | $482M | $539M | $667M | $865M | $1.0B | $1.0B |
| Margins | ||||||||||
| Gross margin | 37.3% | 36.6% | 40.6% | 42.0% | 41.8% | 43.2% | 43.7% | 43.5% | 44.7% | 44.9% |
| Operating margin | 6.2% | 11.7% | 13.5% | 7.1% | 12.2% | 19.2% | 23.1% | 23.5% | 20.7% | 14.2% |
| EBITDA margin | 7.8% | 12.9% | 14.9% | 9.4% | 14.3% | 20.9% | 24.3% | 24.7% | 22.3% | 16.3% |
| Net margin | 4.1% | 30.9% | 10.4% | 5.0% | 10.5% | 14.9% | 19.9% | 21.8% | 19.7% | 14.3% |
| FCF margin | β4.2% | 11.9% | 9.5% | β7.5% | 13.1% | 21.4% | 22.3% | 12.0% | 12.6% | 12.8% |
| Returns | ||||||||||
| Return on capital employed | 6.5% | 11.7% | 12.9% | 5.0% | 10.7% | 21.1% | 27.7% | 26.7% | 18.5% | 10.3% |
| Return on equity | 5.5% | 45.7% | 12.0% | 4.1% | 11.1% | 19.3% | 30.4% | 32.1% | 21.4% | 11.7% |
| Return on assets | 3.6% | 32.1% | 8.9% | 3.1% | 8.5% | 14.3% | 20.7% | 21.5% | 15.3% | 8.9% |
| Return on tangible equity | 5.5% | 35.9% | 11.2% | 4.1% | 10.4% | 18.3% | 27.4% | 28.5% | 19.8% | 11.6% |
| Growth | ||||||||||
| Revenue growth | β | 53.8% | 7.8% | β22.5% | 38.4% | 39.6% | 38.9% | 22.9% | β10.0% | β17.6% |
| Net income growth | β | 1,054.1% | β63.9% | β62.9% | 193.4% | 97.4% | 85.6% | 34.5% | β18.4% | β40.2% |
| EPS growth | β | 955.6% | β64.5% | β63.0% | 192.0% | 97.3% | 89.6% | 36.1% | β17.2% | β38.2% |
| FCF growth | β | β | β13.8% | β160.5% | β | 127.2% | 44.9% | β33.5% | β5.6% | β16.8% |
| Share count change | β | 8.0% | 1.7% | β0.5% | 0.9% | 0.4% | β2.1% | β1.1% | β1.4% | β3.2% |
| Financial health | ||||||||||
| Interest coverage | 3.3x | 9.3x | 11.7x | 4.7x | 11.1x | 26.3x | 38.1x | 49.7x | 38.6x | 22.2x |
| Current ratio | 5.0x | 4.3x | 4.7x | 5.5x | 5.6x | 4.1x | 3.5x | 3.8x | 5.4x | 4.8x |
| Quick ratio | 2.7x | 2.8x | 3.2x | 3.4x | 3.7x | 2.8x | 2.6x | 2.7x | 4.1x | 3.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.9% | 1.8% | 1.1% | 3.5% | 1.6% | 1.3% | 1.2% | 1.8% | 1.2% | 1.3% |
| Stock comp / revenue | 1.9% | 1.4% | 1.8% | 2.4% | 2.2% | 1.8% | 1.5% | 1.6% | 2.1% | 2.5% |
| Payouts / FCF | β | β | β | β | 12.0% | 35.3% | 28.1% | 38.5% | 47.0% | 113.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 5.0 | 4.0 | 6.0 | 6.0 | 7.0 | 5.0 | 5.0 | 4.0 |
| Altman Z'' | 3.1 | 5.5 | 6.6 | 6.6 | 7.7 | 7.8 | 7.9 | 8.5 | 9.8 | 8.7 |
| Accruals ratio | 6.5% | 17.9% | β0.2% | 5.6% | β3.4% | β7.5% | β3.7% | 7.8% | 4.6% | 0.1% |
Source: SEC EDGAR XBRL filings (CIK 0001113232). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.